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Measuring the acute effect of insulin infusion
on ATP turnover rate in human skeletal muscle
using phosphorus-31 magnetic resonance
saturation transfer spectroscopy
Ee Lin Lim
a, Kieren G. Hollingsworth
a, Peter E. Thelwall
a and Roy Taylor
a*
Mitochondrial dysfunction has been proposed to underlie the insulin resistance of type 2 diabetes. However, the
relative time course of insulin action in stimulating ATP turnover rate and glucose uptake in skeletal muscle has not
beenexamined.Thesetwoparametersweremeasuredinyounghealthysubjectsusingthe
31PMRSsaturationtransfer
method in conjunction with the euglycaemic hyperinsulinaemic clamp technique respectively. Glucose infusion rate
rose rapidly from 0 to 2.90W0.11mg/kgffm/min during the ﬁrst 10min of insulin infusion and further to
6.17W0.57mg/kgffm/min between 15 and 45min. In contrast, baseline ATP turnover rate was 9.0W0.4mmol/g/
min of muscle and did not change during the ﬁrst 45min of insulin infusion. Between 50 and 80minutes ATP turnover
rate increased by 8% and remained steady to 150minutes (9.7W0.5 mmol/g/min of muscle, p¼0.03 vs baseline). The
in vivo time course of insulin stimulation of skeletal muscle ATP turnover rate is not consistent with a rate limiting
effect upon the initiation of insulin-stimulated glycogen synthesis. Copyright  2010 John Wiley & Sons, Ltd.
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INTRODUCTION
ATP is the universal energy currency in living cells for supporting
the energy demands of various cellular activities and functions
whilst insulin is the key regulator in fuel metabolism. In healthy
skeletal muscle the majority of ATP production occurs in the
mitochondria by oxidative phosphorylation. Mitochondrial
dysfunction has been reported in skeletal muscle in type 2
diabetes (1), insulin-resistant offspring of type 2 diabetes patients
(2), obesity (3) and in age-related insulin resistance (4,5), and it
has been proposed that there is a causative link between the
impairment of oxidative capacity and pathogenesis of type 2
diabetes in humans (6).
Using phosphorus-31 magnetic resonance spectroscopy
(
31P MRS), several research laboratories have applied magnetiza-
tion saturation transfer methods to calculate unidirectional ATP
synthesisrate(7–9).Using thismethodology,ithasbeenreported
that insulin increases ATP turnover rate in muscle of normal
subjects but not in insulin resistant subjects (10,11). This has led
toawidespreadacceptance thatadefectinATP generationcould
be a direct cause of insulin resistance (2,11–14).
However, all previous studies measured ATP turnover rate in
muscle after an insulin infusion of 2–8 h duration whereas insulin
is a rapidly acting regulator of metabolism which brings
about major metabolic changes within minutes. The time course
of stimulation of ATP turnover rate during the rapid onset of
insulin’s action on metabolic processes has not been previously
examined. We have applied the
31P MRS saturation transfer
method continuously during the ﬁrst 150min of insulin
stimulation in normal subjects to examine whether the time
course of ATP stimulation is consistent with a primary role in
insulin’s metabolic effects.
MATERIALS AND METHODOLOGY
Subjects
Seven healthy volunteers (3 male, 4 female) without family history
of diabetes were studied. None were glucose intolerant or taking
any medication known to affect glucose tolerance or insulin
sensitivity (for example steroids, beta-blockers or diuretics).
Anthropometric and metabolic characteristics of the subjects are
summarised in Table 1. All participants refrained from any physical
exercise during the 3 days preceding the studies and fasted
overnight for 12 h before the experiments. The study protocol was
approved by the Newcastle upon Tyne Research Ethics Committee
2, and informed consent was obtained from all subjects.
31P MRS examinations
Magnetic resonance data were acquired using a 3T Achieva
scanner (Philips, Best, The Netherlands) with an in-built body coil
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2used for imaging and a 14-cm diameter surface coil for
phosphorus spectroscopy. Subjects remained supine inside the
magnetic resonance spectrometer with the phosphorus coil
positioned beneath the left calf during each investigation. To
prevent movement during each study, the coil was secured in
place using fabric straps around the calf. All seven subjects were
studiedtwice onidenticalstudydaysandthefourteensetsofATP
turnover rate measurements obtained were averaged.
ATP turnover rate measurements
Resting ATP turnover was measured using saturation transfer
sequencebetweeng-ATPandPi(7).Foreachmeasurement,the Pi
concentration was estimated from a 1D-ISIS spectrum centred on
the gastrocnemius and soleus muscles (TR¼25 s, 8 averages,
duration 3.3min). Broadband decoupling was applied to data
acquisition in all experiments: the g-ATP resonances were
assumed to have concentration 8.2mM in line with previous
studies (15,16): the resonance frequency was placed mid-way
between the g-ATP and Pi resonances to ensure as even an
excitation as possible at 3T. The pseudo-ﬁrst order rate constant
of the ATP synthase reaction was then estimated by a saturation
transfer experiment as follows. The steady state-magnetization of
Pi was measured during selective irradiation of g-ATP (Mz) and
compared with the equilibrium Pi magnetization with the
irradiationplacedsymmetricallydown-ﬁeldfromthePifrequency
(TR¼25 s, bandwith¼3,000Hz, 2,048 points, 16 averages each,
duration 13.3min) (MO). The resonant frequency was set at the Pi
frequency to allow symmetrical saturation pulses about that
resonance. The fractional reduction of Pi magnetization upon
saturation of g-ATP, (MO–Mz)/ MO, was used to calculate the
pseudo-ﬁrst order rate constant using the Forsen-Hoffman
equation: k1¼[(MO–Mz)/ MO](1/T1
 ), where T1
  is the spin-lattice
relaxation time for the phosphorus nucleus of Pi when ATP is
saturated (17). T1
  was measured using an inversion recovery
experiment (t1–1808–t2–908–acquire, TR¼25 s, 4 averages,
duration 13.3min), while saturation of g-ATP was performed
during the delay times t1 and t2. Broad-band proton decoupling
and 1D ISIS localisation was used. Eight variable t2 time delays
were used ranging from 635–9,035 ms. Therefore the time
required for a complete saturation transfer measurement was
26.7min. Unidirectional turnover rate of ATP synthesis was then
calculated by multiplying the constant k1 by the Pi concentration.
Analysis ofall spectra wasperformed with jMRUI (version 3.0) (18)
using AMARES (19). Prior knowledge was used to solve the
datasets as follows. Single Lorentzian peaks were modelled for
inorganic phosphate (Pi), phosphodiesters (PDE) and phospho-
creatine (PCr). The a- and g-ATP resonances were modelled as
Lorentziandupletsofequalmagnitudeseparatedby18Hz.Dueto
the bandwidth of the pulses used and tuning Pi to be on
resonance, the b-ATP resonance is only weakly detected and is
not modelled. Toﬁt the saturation transfer andinversion recovery
experiments the zero and ﬁrst order phasing and the Pi linewidth
was determined from the control saturation scan. Phase values
were then applied using the previous prior knowledge to ﬁt the
saturation, control and inversion recovery data. This provides
sufﬁcient stability to ﬁt inversion recovery spectra with peaks of
different T1
  value using the AMARES algorithm. Sample spectra
aregiveninFigures1and2.Inpreparatoryworkfor theﬁrststudy
using this implementation of the saturation transfer technique
(9), three healthy, fasting subjects were studied three times on
one day without repositioning of the r.f. coil yielding an intra-day
variability of 6.5% in ATP turnover rate, and were studied twice
more on two further separate days to examine the effect of coil
repositioning, yielding an interday reproducibility of 8% in ATP
turnover rate.
Two consecutive baseline measurements were acquired from
0830 to 0930 ( 60 to  30min and -30 to 0min respectively
relative to the start of infusion) and during the 150min of the
hyperinsulinaemic glucose clamp, four contiguous measure-
ments were performed (15–45min, 50–80min, 85–115min, and
120–150min). Owing to the fact that it takes 27minutes to
acquire data to measure the pseudo-ﬁrst order rate constant, k1,
and that Pi concentration can increase across this time, it was
decided to take the average of two measurements of Pi
concentration before and after the saturation transfer measure-
ment of k1 in every case for calculations of ATP turnover rate.
Glucose clamp studies
For all experiments, participants travelled to the magnetic
resonance facility by taxi and were transported within the centre
bywheelchair.At0800( 90min),onecannulawasinsertedintoa
large antecubital vein for administration of intravenous glucose
and insulin. A second cannula was inserted into the contralateral
wrist vein for the purpose of blood sampling. Use of a hand
warming device ensured arterialisation of venous blood.
Table 1. Clinical characteristics of study subjects. Values are
means SE
Male : female 3 : 4
Age (years) 28 2
Weight (kg) 66.6 6.6
Body Mass Index (kg/m
2) 22.9 1.7
Fat mass (kg) 14.9 1.4
Fat free mass (kg) 51.7 5.4
Estimated body fat (%) 22.6  1.1
Fasting blood glucose (mmol/l) 4.6 0.1
Fasting plasma insulin (pmol/l) 49 6
HbA1C (%) 5.3 0.2
- -1 0 5 0 5 10 ppm
Control
Saturated
PCr
Pi γ-ATP
Figure 1. Patient spectra from the saturation transfer measurement
showing (bottom) the saturation of g-ATP at -2.38ppm and (top) the
control saturation at (2.38ppm). The differences in the amplitudes of PCr
and Pi show the saturation transfer effect.
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3Conditions of fasting glycaemia and standardised hyperinsuli-
naemia were achieved for 150min using the euglycaemic
hyperinsulinaemic clamp technique (20). Insulin (Actrapid;
NovoNordisk, Bagsvaerd, Denmark) was administered from
0930 to 1200 (0–150min) as a primed-continuous infusion
(primed followed by 40 mU/m
2/min). The fasting blood glucose
concentration for each subject was maintained by adjusting the
infusion rate of a 20% dextrose solution based on blood glucose
measurements performed at 5min intervals. Whole body insulin
sensitivity was determined from calculated whole body glucose
disposal during the last 30min of the hyperinsulinaemic glucose
clamp (20). Glucose infusion rate was assumed to represent
whole body glucose disposal since endogenous glucose release
is negligible at this level and duration of hyperinsulinaemia in
normal subjects (21).
Blood glucose and plasma insulin
Blood glucose concentration was measured by the glucose
oxidase method (YSI glucose analyser; YSI, Yellow Springs, OH).
Plasma insulin concentration was measured using an enzyme-
linked immunosorbent assay kit (DAKO, Ely, UK). Blood
glycosylated haemoglobin (HbA1C) level was measured as an
indicator of average blood glucose control in the preceding
8 weeks usinghigh performance liquid chromatography (TOSOH,
Tokyo, Japan).
Statistical analysis
Statistical analyses were performed using SPSS 15.0 software
(SPSSInc.,Chicago,USA).Dataarepresentedasmeans SEinthe
text and in the ﬁgures, unless otherwise stated. Prior to any
comparisons, distribution was tested for normality using the
Shapiro-Wilk W-test. For our study of seven subjects, non-
parametric Wilcoxon test was used to determined within group
differences (22). Statistical signiﬁcance was accepted at p<0.05.
RESULTS
Whole body glucose metabolism
Mean blood glucose concentration during baseline measure-
ment was 4.6 0.1mmol/l and was maintained at this
concentration during the euglycaemic hyperinsulinaemic period
(4.7 0.1 vs 4.6 0.1mmol/l). Fasting plasma insulin concen-
tration was 49 6 pmol/l, and this increased approximately
10-fold within 15min of the clamp. Plasma insulin concentration
remained constant for the duration of the clamp (456 19 pmol/
l, p<0.001 vs baseline). A rapid increase in whole body glucose
disposal rate was observedvia a rise ofglucose infusion rate from
0 to 2.90 0.11mg/kgffm/min during the ﬁrst 10min and further
to 6.17 0.57mg/kgffm/min between 15–45min (Fig. 3). There
was a subsequent slower increase to 8.31 0.67mg/kgffm/min
during the 120–150min period.
Resting ATP turnover rate
Mean baseline ATP turnover rate was 9.0 0.4mmol/g/min of
muscle. During the ﬁrst 45min of the clamp, there was no
increase in ATP turnover rate to match the acute onset of the
metabolic actions of insulin reﬂected by the steep increase in
glucose utilisation. Between 50 and 80min after the insulin
infusion was commenced, ATP turnover rate increased by 8% and
remained steady until the end of the clamp (9.7 0.5mmol/g/
min of muscle, p¼0.03 vs baseline).
The average of the two Pi concentration acquired at baseline
was 3.62 0.07mmol/l. Pi concentration did not change during
the early period of insulin infusion (15–45min period:
3.58 0.08mmol/l, p¼0.463). Thereafter, Pi concentration
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Figure 3. Simultaneous time course change in ATP turnover rate
(represented in histogram bars) and glucose infusion rate (solid line)
during the euglycaemic hyperinsulinaemic clamp.
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4increased to 3.98 0.09mmol/l between 50 and 80min (p<0.05
vs baseline). This corresponded to a 14% increase compared to
baseline (Table 2).
There was no signiﬁcant change in k1 for ATP turnover rate
between baseline and insulin-stimulated conditions (Table 2).
This was reﬂected by there being no signiﬁcant change in either
the T1
  of Pi (the longitudinal relaxation time during g-ATP
saturation) or the fraction ofPi signal during saturation compared
to control saturation (Mz/M0) under insulin stimulation. As k1 was
unchanged, all change in ATP turnover rate was derived from
change in Pi concentration.
DISCUSSION
To our knowledge, this is the ﬁrst study to investigate the acute
effect of insulin on muscle ATP turnover rate, and to track the
time course of ATP turnover rate during physiological hyper-
insulinaemia. Insulin is responsible for increasing whole body
glucose disposal mainly by stimulating glycogen synthesis in the
transition from fasted to fed state (23). Carbon-13 magnetic
resonance spectroscopy studies have shown physiological
hyperinsulinaemia to increase muscle glycogen concentration
in as little as 15min in healthy individuals (24,25), which is
reﬂected in the rapid increase in glucose disposal rate observed
in our experiments.
The glucose infusion rate data shown in Figure 3, illustrate that
the highest rate of change in glucose disposal occurs in the ﬁrst
30–60min of euglycaemic hyperinsulinaemia. The ATP turnover
rate was unchanged during the ﬁrst 20–50min of the clamp, with
an 8% increase after 50min. There are notable differences with
other reported measurements of ATP turnover rate during
physiological hyperinsulinaemia. The single most important
difference lies in the timing of the measurements. The original
report of mitochondrial dysfunction associated with diabetes
measured ATP turnover rate averaged over 30–150min of
euglycaemic hyperinsulinaemia (10) while subsequent studies
compared the later effects (120–350min) of insulin stimulation of
ATP turnover rate (8,11). The long scan duration limited the time
resolution and prevented examination of time course. However,
in order to determine the relationship between parameters it is
important to measure ATP turnover rate during the onset of
insulin action, as early as 15min of insulin stimulation (24). Other
processes, separate from insulin’s effect on muscle glycogen
synthesis, such as insulin’s effect on mitochondrial fusion and
proliferation (26,27) and mitochondrial protein synthesis (28),
may affect ATP turnover rate on a timescale of 4–8h of insulin
stimulation. These processes are temporally dissociated from and
not relevant to the early metabolic effects of insulin. They are
likely to affect data on ATP turnover rates in the longer studies of
prolonged hyperinsulinaemia.
In the present study insulin stimulation for 150min brought
about an 8% increase in ATP turnover rate, less than the 11–90%
previously observed in normal control subjects in the literature
(2,11). The report of a 90% increase in ATP turnover rate in
insulin-sensitive subjects with insulin stimulation (2) related to
extremephenotypesofinsulin sensitivity.Additionally,theinsulin
resistant offspring were reported to have a low basal resting ATP
turnover rate. This has not been conﬁrmed in subsequent studies
comparing subjects with and without type 2 diabetes when
subjects have been matched for habitual physical activity (9,11).
During a 240min period of hyperinsulinaemia, Szendroedi et al.
reported a 10.5% increase in ATP turnover rates in the diabetic
subjects, 10.6% in the age matched controls, and a 26% increase
in ATP turnover rate in the young controls (11). It has been widely
postulated within the MR and diabetes communities that defects
in mitochondrial function may underlie the reduced glucose
disposal rate during hyperinsulinaemia in type 2 diabetes
(11–14). Although the data suggest a relationship between
insulin sensitivity and ATP turnover rate, this does not indicate
cause and effect. Hence, the extrapolation of hypothesis from the
original observations (2) to the pathophysiology of type 2
diabetes itself has not been well justiﬁed.
In addition to the shorter period of insulin stimulation
examined in the present study as explanation for observing a
lesser magnitude of increase of ATP turnover rate with insulin,
other factors such as surface coil placement, coil diameter and
acquisition sequences could affect the results in comparing
between studies. The relative composition of the r.f. coil’s
sensitive volume of gastrocnemius and soleus muscles requires
consideration as soleus muscle, which has predominantly Type I
muscle ﬁbres, has been shown to have higher resting ATP
turnover rate than gastrocnemius (29). We used a larger coil than
used by Szendroedi et al. (11) (14cm diameter compared to
10cm) and thus would expect to have a higher percentage of
contribution of signal from the soleus muscle.
ATP turnover rate is calculated from both the intramyocellular
Pi concentration and the measured rate constant k1. To ensure
our estimates of ATP turnover rate were as accurate as possible
duringtherapidlychangingPiconcentrationintheﬁrsthourafter
insulin stimulation, the average of the Pi concentrations before
and after the 27-min saturation transfer measurement was used.
We observed insulin-stimulated Pi concentration to increase by
14% until the end of the euglycaemic hyperinsulinaemic clamp,
in agreement with previous studies (11,30). The concentration of
Pi in the muscle tissue maybe an important mechanism by which
Table 2. Components of the ATP turnover rate measurement at baseline and during insulin stimulation. Values are means SE
Baseline
During Isoglycaemic hyperinsulinaemic clamp
15–45 min 50–80 min 85–115 min 120–150 min
k1 (s
 1) 4.09 0.18 3.89 0.20 3.91 0.27 4.01 0.26 4.08 0.29
Pi (mmol/l) 3.62 0.07 3.58 0.08 3.98 0.09 3.99 0.13 3.90 0.11
T1
  (s) 4.00 0.10 4.30 0.12 4.10 0.15 4.25 0.15 4.08 0.12
Mz/M0 (-) 0.73 0.01 0.72 0.01 0.73 0.01 0.72 0.01 0.73 0.01
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5insulin regulates ATP synthesis (31): there was no change in
measured reaction rate, k1 across the two hour duration of this
clamp, or in any of the parameters measured to calculate k1. Such
changes were implied by the early work in this ﬁeld on young
insulin sensitive volunteers (2,10).
Measurements of ATP turnover rate by
31P saturation transfer
method report ﬂux of ATP through Pi incorporation into ATP, and
are thus comprised of ATP generated by glyceraldehyde-3-
phosphate dehydrogenase and 3-phosphoglycerate kinase
reactions as well as by ATP synthase. This could result in a
mismatch between oxygen consumption and ATP synthesis (32),
as demonstrated in studies performed in aerobic yeast
suspensions Saccharomyces cerevisiae (32) and perfused rat
myocardium (33).However,arterio-venousbalancestudiesacross
the leg have shown that there is no net export of lactate from
human muscle following insulinisation in either type 2 diabetic
subjects or leaner normal controls such as used in the present
study (34). This net measurement does notexcludethe possibility
of a change in redundant cycling of 3-carbon compounds
through the glycolytic exchange ﬂux, but the extent to which this
cycling contributes to the observed rate of overall ATP turnover
still remains to be determined (35).
A hallmark of muscle physiology is the ability to support a high
energy demand for muscle function by phosphocreatine
buffering of ATP, and by aerobic and anaerobic respiration. Thus
postulation that muscle glycogen synthesis may be limited by
ATP production, especially in resting muscle where ATP capacity
is high, seems at odds with muscle function. In support of this,
more recent reconsideration of the data supporting mitochon-
drial dysfunction as pathogenic for type 2 diabetes has
concluded that the cause-and-effect relationship between
mitochondrial dysfunction and insulin resistance is not sup-
ported by all data (9,36,37).
For the ﬁrst time, the early time course of skeletal muscle ATP
turnover in response to insulin has been quantiﬁed in young,
healthy controls. There was no increase in ATP turnover rate
during the ﬁrst hour of administering a high physiological
concentration of insulin, the timescale where glycogen synthesis
is initiated. ATP turnover rate was observed to increase only after
1 h, indicating that glycogen synthesis is not limited by ATP
availability in healthy controls, with implications for hypotheses
abouttheoriginsofdefectiveinsulinsensitivityintype2diabetes.
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